FIELD: veterinary medicine.
SUBSTANCE: method involves a joint application of the Aminoseleton tissue specimen on days 1, 3 and 5 of the treatment course, which is administered subcutaneously in the upper third of the neck at a growing dose of 40-45-50 ml. The immunomodulator is administered in a dose of 10 ml intramuscularly on days 2, 4 and 6 of treatment. Bovine recombinant interferons α and γ are used as an immunomodulator.
EFFECT: method is highly effective for the treatment of subclinical mastitis in lactating cows.
3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING SUBCLINICAL MASTITIS IN LACTATING COWS | 2021 |
|
RU2768609C1 |
METHOD FOR THE TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2022 |
|
RU2783249C1 |
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2013 |
|
RU2538721C1 |
TREATMENT OF MASTITIS IN LACTATING COWS | 2022 |
|
RU2796986C1 |
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2010 |
|
RU2441660C1 |
METHOD FOR COMPLEX THERAPY OF MASTITIS IN LACTATING COWS | 2020 |
|
RU2756125C1 |
METHOD OF PREVENTION MASTITIS OF LACTATING COWS | 2018 |
|
RU2683289C1 |
METHOD FOR PREVENTING MASTITIS IN LACTATING COWS | 2019 |
|
RU2731476C1 |
PREVENTION OF MASTITIS IN LACTATING COWS | 2023 |
|
RU2804852C1 |
METHOD FOR THE TREATMENT OF ACUTE POSTPARTUM ENDOMETRITIS IN COWS | 2020 |
|
RU2746297C1 |
Authors
Dates
2017-05-18—Published
2016-11-15—Filed